Newsfeeds - Spark Newswire

1 minute read

Chardan Capital Initiates Coverage On Presto Technologies with Neutral Rating, Announces Price Target of $4.25

Today, 2:51 PM

Chardan Capital analyst Brian Dobson initiates coverage on Presto Technologies (NASDAQ:PRST) with a Neutral rating and announces Price Target of $4.25.

PRST

1 minute read

Presto Technologies Q3 EPS $0.71, Sales $7.80M

By Benzinga Newsdesk

Today, 2:51 PM

Presto Technologies (NASDAQ:PRST) reported quarterly earnings of $0.71 per share. The company reported $7.80 million in sales this quarter.

PRST

5 minute read

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:51 PM

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.

ACOR

3 minute read

Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 2:51 PM

Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its existing portfolio.

AHI

6 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 2:51 PM

On Thursday, 111 stocks hit new 52-week lows.

ADIL

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 2:51 PM

On Monday, 413 companies reached new 52-week lows.

AAN

5 minute read

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:51 PM

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS